Knox Lane's $437M Take-Private: The PE Playbook for Buying Distressed Public Companies

That prior process likely gave Cross Country's board a clearer sense of the company's standalone value and its willingness to transact. It also cleared a competitor from the field. Knox Lane's offer did not have to compete with another financial sponsor or a second strategic bidder. The 31% premium they paid was enough to satisfy the board and shareholders without triggering an auction that might have driven the price higher.

For investors watching this sector, the failed strategic deal followed by a successful financial sponsor deal is a recognizable pattern. It often signals that the asset's value is real but that strategic buyers face constraints that pure-play PE firms do not.

How Returns Work for LPs

Limited partners in PE funds do not buy individual deals. They commit capital to a fund, which deploys that capital across a portfolio of companies over three to five years. Understanding how returns are generated on a deal like Knox Lane's Cross Country acquisition helps LPs assess whether they want exposure to this type of strategy.

Entry multiples in healthcare staffing PE transactions currently run between 7x and 9x EBITDA for platform acquisitions. Bolt-on acquisitions (smaller companies added to the platform after the initial deal) typically price at 4x to 6x EBITDA. That multiple arbitrage is one of the clearest return drivers in PE. You buy a $20 million EBITDA bolt-on at 5x for $100 million, integrate it into a platform that will exit at 9x EBITDA, and the combined company's value reflects that higher multiple across all earnings.

Median exit multiples in healthcare staffing PE have run around 9.2x EBITDA in recent vintages. Hold periods in the current rate environment are running seven or more years as PE firms wait for credit conditions to improve and public market exit windows to open. That extended hold period has real implications for LP liquidity planning.

Value creation in a deal like this does not come primarily from revenue growth. Knox Lane's thesis likely centers on four operational levers. First, redeployment rates: the percentage of healthcare workers who complete an assignment and immediately accept another. Higher redeployment cuts recruiting cost per placement dramatically. Second, margin expansion through operational efficiency and reduced overhead at the public company level. Third, compliance infrastructure — healthcare staffing firms face strict Joint Commission and state licensing requirements, and firms that build strong compliance systems win contracts that smaller competitors cannot service. Fourth, customer diversification away from any single hospital system or geography that could renegotiate rates aggressively.

If Knox Lane can add two or three bolt-on acquisitions at 5x EBITDA, grow the combined platform's EBITDA by 40% over a seven-year hold, and exit at 9x, the return math works comfortably. That is not a guarantee. It is a thesis that depends on management execution and market conditions at exit.

What Accredited Investors Should Look for in Sector PE Funds

Healthcare staffing PE is a specific sub-sector with distinct risk factors. Accredited investors evaluating fund exposure should press GPs on the following points.

Reimbursement risk. A meaningful portion of healthcare staffing revenue flows through Medicaid and Medicare-funded facilities. Changes to federal reimbursement rates directly affect what hospitals can pay temporary workers. Ask the GP how the fund models downside scenarios tied to CMS rate changes.

Regulatory and licensing concentration. Some staffing specialties, travel nursing in particular, face state-level restrictions on bill rates and contract terms. California has enacted staffing ratio legislation that affects how hospitals structure temporary labor. Funds with heavy California or Northeast exposure carry different regulatory risk than those diversified across Sun Belt markets.

Bolt-on pipeline quality. Ask for the GP's acquisition pipeline and their diligence criteria for bolt-ons. Fragmented sectors attract PE capital precisely because bolt-on opportunities are abundant, but poor integration execution destroys value faster than organic growth can rebuild it.

Management team retention. Take-privates sometimes disrupt leadership teams that were accustomed to public company compensation structures and visibility. Ask whether the GP has retained the key operators or brought in a new management team, and why.

Fund vintage and rate environment. Funds raised in 2023 and 2024 deployed capital at higher interest rates, which affects the cost of acquisition debt and the IRR math on exit. The Federal Reserve's rate path between now and the fund's exit window (2030-2033 for a fund investing today) is a genuine uncertainty. A fund targeting 20%+ gross IRR needs clean execution across every variable.

Alignment of incentives. Standard GP economics are 2% management fee and 20% carried interest above an 8% preferred return hurdle. Confirm that the fund you are evaluating does not charge portfolio company fees that reduce LP net returns. The SEC has scrutinized fee disclosure practices in PE for years; reputable managers disclose all fee streams clearly.

Frequently Asked Questions

What is a take-private and why do PE firms prefer it to buying private companies outright?
A take-private involves buying a publicly listed company and delisting it. PE firms pursue public targets because public market dislocations create pricing inefficiencies. The stock market can undervalue a company's earnings power in a cyclical trough. Private companies, by contrast, are usually sold by owners who negotiate on current earnings, not depressed cycle earnings. Public targets sometimes offer better entry pricing precisely because the stock market is short-term.

How does the 31% premium affect LP returns?
The premium is the price of entry. Knox Lane paid $13.25 per share versus a $10.12 close on May 6. That premium raises the acquisition cost, which means the company needs to generate more EBITDA growth and exit at a higher multiple to hit return targets. A 31% premium is meaningful but not extreme for a take-private with a clear operational thesis. The 45% premium to the 90-day VWAP suggests the stock had already been depressed for an extended period, which partially offsets the premium paid.

What happened to Cross Country employees and operations after the deal closed?
Public disclosures on post-close operational plans are limited at this stage. PE-backed take-privates of platform companies generally do not immediately restructure operations. Knox Lane's value creation thesis depends on the existing business continuing to function while the firm adds bolt-on acquisitions and improves operational metrics. Significant headcount reductions at the platform level would undermine the redeployment rate improvements that drive returns.

Can accredited investors access Knox Lane's funds directly?
Knox Lane is a Los Angeles-based PE firm focused on consumer and healthcare services. Like most mid-market PE firms, it raises capital from institutional LPs, including pension funds, endowments, and family offices, rather than individual accredited investors. Accredited investors seeking this type of exposure typically access it through fund-of-funds vehicles, secondary funds, or co-investment platforms that aggregate individual capital into institutional-grade commitments. Minimum check sizes at the GP level typically start at $5 million or higher.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.